3.37

3.37 (-0.47%)

As of Feb 23, 2024

ALIMERA SCIENCES INC [ALIM]

Source: 

Company Overview

Alimera Sciences, Inc. and its subsidiaries is a commercial-stage, global pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a leading cause of blindness, and for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS).

CountryUS
Headquartersalpharettageorgia
Phone Number(678) 990-5740
Industrypharmaceutical preparations
CEORichard S. Eiswirth, Jr.
Websitealimerasciences.com